How do you counsel patients on VTE prevention during prolonged travel (≥4 hours), and how does your approach differ based on individual VTE risk factors (e.g., obesity, active cancer, prior VTE)?
When do you recommend nonpharmacologic measures (e.g., ambulation, compression stockings), pharmacologic prophylaxis (e.g., aspirin, LMWH, DOACs), both, or neither?
Community PollStarted
What VTE prevention strategies do you recommend for prolonged travel in patients with increased VTE risk?
6 physicians have voted
Join Mednetto vote and see how they answered.